Summary
Acetylsalicylic acid (aspirin) is ineffective in reducing perioperative heart attacks and death in noncardiac surgery, but increases the risk of bleeding. Results from the Perioperative Ischemic Evaluation-2 trial [POISE-2; Devereaux PJ et al. N Engl J Med 2014] are discussed in this article.
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Myocardial Infarction
- Interventional Techniques & Devices
- Cardiology Clinical Trials
- Cardiology & Cardiovascular Medicine
- Myocardial Infarction
- © 2014 MD Conference Express®
Tools
Perioperative Aspirin Does Not Reduce Cardiovascular Events in Noncardiac Surgery (POISE-2)
Permalink:
Table of contents
Cited By...
- No citing articles found.